参 考 文 献

1 Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl):338 - 400.

2 Anderson FA Jr, Spencer FA.Risk factors for venous thromboembolism. Circulation,2003 ,107(23 Suppl 1) : 9 - 16.

3 Liew NC, Moissinac K, Gul Y. Postoperative venous thromboembolism in Asia: a critical appraisal of its incidence. Asian J Surg ,2003, 26: 154 - 158.

4 Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest, 2001, 119（1 suppl）:132 - 175.

5 Turpie AG, Bauer KA, Eriksson BI, et al. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med ,2002, 162 : 1833 - 1840.

6 Fitzgerald RH Jr, Spiro TE, Trowbridge AA, et al. Prevention of venous thromboembolic disease following primary total knee arthroplasty. J Bone Joint Surg(Am), 2001,83: 900-906.

7 Kearon C. Duration of venous thromboembolism prophylaxis after surgery. Chest ,2003,124(6 Suppl ): 386 - 392.

8 O’Donnell M, Linkins LA, Kearon C, et al. Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review. Arch Intern Med, 2003, 163: 1362 - 1366.

9 Samama CM, Vray M, Barre J, et al. Extended venous thromboembolism prophylaxis after total hip replacement:a comparison of low-molecular-weight heparin with oral anticoagulant. Arch Intern Med, 2002, 162: 2191 - 2196.

10 AIDA: 45th American Society of Hematology Annual Meeting. San Diego，2003.

11 Hardwick ME, Colwell CW Jr. Advances in DVT prophylaxis and management in major orthopaedic surgery. Surg Technol Int,2004,12: 265 - 268.

12 Dahl OE, Aspelin T, Lyberg T.The role of bone traumatization in the initiation of proximal deep vein thrombosis during cemented hip replacement surgery in pigs. Blood Coagul Fibrinolysis, 1995, 6: 709 - 717.

13 Hull RD, Pineo GF, Stein PD, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med, 2001, 135: 858 - 869.

14 Hull RD, Pineo GF, Francis C, et al. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison.North American Fragmin Trial Investigators.Arch Intern Med, 2000, 160: 2208 - 2215.

15 Lee A, Agnelli G, Buller H, et al. Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein C2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation, 2001, 104: 74 - 78.

本新闻共7页,当前在第6页  1  2  3  4  5  6  7